Item 8.01 Other Events.



On October 7, 2020, Kindred Biosciences, Inc. (the "Company") and its
wholly-owned subsidiary, Centaur Biopharmaceutical, Inc. ("Centaur"), issued
respective press releases announcing the Company has expanded its agreement with
Vaxart, Inc. ("Vaxart") for the manufacture of Vaxart's oral vaccine for
COVID-19 and other vaccine candidates, with manufacturing services to be
performed by Centaur. Copies of the press releases by the Company and Centaur
are attached to this Current Report on Form 8-K as Exhibits 99.1 and 99.2 and
are incorporated herein by reference.


Item 9.01  Financial Statements and Exhibits.
Exhibit No.                 Description
        99.1                  Press Release of Kindred Biosciences, Inc. issued on October 7, 2020
        99.2                  Press Release of Centaur Biopharmaceutical, Inc. issued on October 7,
                            2020
        104                 Cover Page Interactive Data File (embedded

within the Inline XBRL document)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses